Philip A. Iredale

Increases in intracellular calcium via activation of an endogenous P₂‐purinoceptor in cultured CHO‐K1 cells

Philip A. Iredale, Stephen J. Hill · British Journal of Pharmacology · 1993 · 139 citations · Full text

Life Sciences, Cell Biology, Physiology +16

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy et al. · Neuropharmacology · 2006 · 132 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Discovery of Two Clinical Histamine H ₃ Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys

Xuebing Cao, Liang Li, John R. Hadcock et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 101 citations

Life Sciences, Neuroscience, Pharmacology +17

Role of Corticotropin‐Releasing Factor Receptor‐1 in Opiate Withdrawal

Philip A. Iredale, John D. Alvaro, Young-Lim Lee et al. · Journal of Neurochemistry · 2000 · 98 citations · Full text

Medicine, Neuroscience, Pharmacology +13